Pharma channel feed

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’ 

Yesterday
FDA+

FDA's on­col­o­gy ad­comm to re­view GSK's Blenrep re­launch plans

Yesterday
FDA+

With HIV pre­ven­tion un­der at­tack, how might Gilead’s new PrEP in­jec­tion fare?

2 days ago
In Focus

Mod­er­na wins ex­pand­ed la­bel for RSV shot, al­low­ing use in at-risk, younger adults

2 days ago
FDA+

Min­neso­ta gener­ic drug pric­ing law is like­ly un­con­sti­tu­tion­al, ap­peals court rules

2 days ago
Law

No­vo Nordisk plans Phase 3 tri­als of oral, in­jectable amy­cretin for ear­ly 2026

2 days ago
R&D

Kennedy's vac­cine doubts hinge on 'in­ert' place­bos, but ex­perts say he mis­un­der­stands the sci­ence

2 days ago
FDA+

In sur­prise, FDA ap­proves Uro­Gen's chemo-turned-gel drug af­ter neg­a­tive ad­comm vote

2 days ago
FDA+

Ex­clu­sive: Kennedy picks for vac­cine ad­vi­so­ry board were paid ex­perts against Mer­ck in civ­il cas­es

2 days ago
R&D
FDA+

RFK Jr. names eight new ACIP mem­bers, in­clud­ing pop­u­lar vac­cine crit­ic Robert Mal­one

3 days ago
FDA+

Trump of­fi­cials seek price de­tails and weigh con­sumer sales as they ex­am­ine most fa­vored na­tion plan

3 days ago

Trump’s HHS urges against re­viv­ing Cham­ber of Com­merce’s IRA law­suit

3 days ago
Law

Fed­er­al of­fi­cials sched­ule three lis­ten­ing ses­sions this sum­mer to ad­dress drug com­pe­ti­tion

3 days ago

Nu­va­tion Bio scores first FDA ap­proval for new lung can­cer drug

3 days ago
FDA+

Have sky-high sales pro­jec­tions set the obe­si­ty mar­ket up to fail?

4 days ago
In Focus

Ver­tex lays off 125 work­ers af­ter type 1 di­a­betes cell ther­a­py failed study in March

4 days ago
People
Cell/Gene Tx

Ar­genx says its drug Vyv­gart looks promis­ing in two more au­toim­mune dis­eases

4 days ago
R&D

FDA’s Makary says he wasn’t part of de­ci­sion to gut ACIP, de­fers pos­si­ble VRB­PAC changes to Prasad

4 days ago
R&D
FDA+

GoodRx goes toe-to-toe with Hims, Ro as it push­es in­to ED treat­ment

5 days ago
Health Tech

Up­dat­ed: HHS chief Kennedy re­moves all ACIP mem­bers, dis­man­tling vac­cine board

5 days ago
FDA+

FDA adds bio­mark­er lim­its to stom­ach, esophageal can­cer la­bels for Mer­ck­'s Keytru­da and BM­S' Op­di­vo

5 days ago
FDA+

Up­dat­ed: Mer­ck wins FDA ap­proval for RSV an­ti­body drug, mak­ing a hot mar­ket more com­pet­i­tive

5 days ago
R&D
FDA+

In a break from oth­er biotechs, Twist Bio­science throws sup­port be­hind tar­iffs on syn­thet­ic DNA

5 days ago
Manufacturing

Sanofi leans in­to 'first-mover ad­van­tage' by ship­ping Bey­for­tus ear­ly, as RSV an­ti­body mar­ket set to heat up

6 days ago
Manufacturing
1234 Next page Last page
A service from the Financial Times